HomeMAZE • NASDAQ
add
Maze Therapeutics Inc
Previous close
$42.30
Day range
$41.46 - $42.92
Year range
$6.72 - $43.29
Market cap
2.02B USD
Avg Volume
490.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.96M | 23.33% |
Net income | -30.09M | -21.55% |
Net profit margin | — | — |
Earnings per share | -0.66 | — |
EBITDA | -32.39M | -38.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 383.94M | 156.63% |
Total assets | 422.06M | 119.27% |
Total liabilities | 42.62M | -54.22% |
Total equity | 379.44M | — |
Shares outstanding | 48.12M | — |
Price to book | 5.36 | — |
Return on assets | -22.72% | — |
Return on capital | -23.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -30.09M | -21.55% |
Cash from operations | -24.64M | -6.19% |
Cash from investing | -66.88M | -64,834.95% |
Cash from financing | 143.76M | 6,786.37% |
Net change in cash | 52.23M | 305.17% |
Free cash flow | -14.83M | 8.60% |
About
Founded
2017
Headquarters
Website
Employees
125
